search
Back to results

Hysteroscopic Monopolar and Bipolar Resection

Primary Purpose

Menorrhagia, Fibroid, Polyps

Status
Unknown status
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Hysteroscopic resection of fibroids, polyps and endometrium.
Sponsored by
Ullevaal University Hospital
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional trial for Menorrhagia focused on measuring Hysteroscopic resection, Menorrhagia, fibroids, polyps

Eligibility Criteria

18 Years - 60 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:-Pre-or perimenopausal women with a bleeding disorder with or without fibroids or polyps - Exclusion Criteria:-Postmenopausal patient. Infertility. Additional condition requiring treatment detected during examination. Malignancy or atypical hyperplasia detected by histological examination. -

Sites / Locations

  • Gynaecological department Ullevaal University HospitalRecruiting

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
May 9, 2006
Last Updated
May 9, 2006
Sponsor
Ullevaal University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT00323999
Brief Title
Hysteroscopic Monopolar and Bipolar Resection
Official Title
A Randomised Trial to Compare the Differences Between Monopolar Surgery (Loop Resection) With Glycine 1,5% and Bipolar Surgery With Saline (Olympus,Versapoint) on Hysteroscopic Surgery.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2006
Overall Recruitment Status
Unknown status
Study Start Date
December 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2007 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Ullevaal University Hospital

4. Oversight

5. Study Description

Brief Summary
The aim of the study is to evaluate bipolar equipment versus monopolar, and to see if there is any differences between the two types of bipolar equipment espescially regading both safety and effect.
Detailed Description
Trial design: A prospective randomised study with three arms, one arm with monopolar surgery and two different arms with bipolar surgery. Its a one center study. Trial population: Pre-or perimenopausal women reffered to our clinic with bleeding disorders and were we plan to do endometrial resection. Patients with a bleeding disorder due to fibroids type 0 and 1 will be included and patients with polyps were endometrial resection is planned at the same time will also be included. Preoperative selection: The fibroids will be mapped using transvaginal ultrasound according to the classification ESGE. Type 0 and 1 fibroids will be included. Diameter of the fibroid must not extend 4cm. The endometrium size double layer will be recorded. Uterine size anetrior /posterior diameter, longitudinal diameter (cavity; top fundal to isthmus) will be measured. Were polyps are included these will be measured; length and width. Higham score (PBAC), Se-hgb, Ferritin, FSH and Oestradiol will be documented at all visits. Menstrual pain will be documented due to a VAS-scale. Treatment regimen:Randomisation in blocs of 20 between monopolar and two types of bipolar surgery. Surgical Technique: The cervical canal will be dilated to Hegar 10 or 11 and a rigid resectoscope Ch. 26 is passed to the uterine cavity. Glycine 1,5% or Saline (Baxter) is infused to irrigate the uterine cavity (Iglesias technique) Automatic pressure cuff maintains an infusion pressure of 100mm Hg and suction 10-15mmHg is applied to the outflow tube in order to achieve a sufficient flow.Fibroids type 0 and 1 are resected in total if possible or flush to the plane of the uterine wall. The tissue chips are removed at intervals by currette and forceps. The operation will be performed by experienced surgeons. Primary response variables: Safety is our primary response variable. Fluid absorption and lowering of Se-Sodium will be analysed. These parameters are the only objective parameters which can tell us about safety. Nausea will be reorded on a VAS-scale. Secondary resonse variables: Operating time, tissue removed, easisness of operation, levels of vaginal bleeding measured by the methosd of Hgham(PBAC)before and at follow up. After 6 month and one year we will look at secondary intervention like repeated resection or hysterectomy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Menorrhagia, Fibroid, Polyps
Keywords
Hysteroscopic resection, Menorrhagia, fibroids, polyps

7. Study Design

Study Phase
Not Applicable

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
Hysteroscopic resection of fibroids, polyps and endometrium.

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:-Pre-or perimenopausal women with a bleeding disorder with or without fibroids or polyps - Exclusion Criteria:-Postmenopausal patient. Infertility. Additional condition requiring treatment detected during examination. Malignancy or atypical hyperplasia detected by histological examination. -
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anette Berg, MD
Phone
+4795219282
Email
anette.berg@uus.no
First Name & Middle Initial & Last Name or Official Title & Degree
Olav Istre, MD., PhD.
Phone
+4741302221
Email
oistre@c2i.net
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Olav Istre, MD., PhD.
Organizational Affiliation
Department of Gynaecology, Ullevaal University Hospital, Oslo, Norway
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gynaecological department Ullevaal University Hospital
City
Oslo
Country
Norway
Individual Site Status
Recruiting

12. IPD Sharing Statement

Learn more about this trial

Hysteroscopic Monopolar and Bipolar Resection

We'll reach out to this number within 24 hrs